More Post from the Author
- MongoDB, Inc. to Present at the UBS Global Technology and AI Conference, the 53rd Annual Nasdaq Investor Conference, and Barclays 23rd Annual Global Technology Conference
- Vision Marine Technologies Reports FY 2025 Results and Highlights Strategic Expansion Following Nautical Ventures Acquisition
- ALLUONE Launches Customized Solution as the Plant-Care Market Continues to Grow
- Nagarro s'tend au Japon avec l'acquisition d'Inaho Digital Solutions
- Bitwise Asset Management Unleashes the Bitwise Dogecoin ETF (NYSE: BWOW)
Alvogen Issues Voluntary Nationwide Recall for One Lot of Fentanyl Transdermal System 25 mcg/h Due to a Defective Delivery System
Published on Mon 3 Feb 2025 2:31:05 UTC
Company Contact Information
Consumers:
866-770-3024
[emailprotected]
Press:
[emailprotected]
MORRISTOWN, N.J., Jan. 31, 2025 /PRNewswire/ -- Alvogen, Inc. is voluntarily recalling one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches to the consumer level. The reason for the recall is that there is a potential that patches could be multi-stacked, adhered one on top of the other, in a single product pouch. This transdermal system is manufactured by Kindeva Drug Delivery L.P., Northridge, CA and is distributed by Alvogen, Inc. as a private label distributor.
More Post from the Author
- MongoDB, Inc. to Present at the UBS Global Technology and AI Conference, the 53rd Annual Nasdaq Investor Conference, and Barclays 23rd Annual Global Technology Conference
- Vision Marine Technologies Reports FY 2025 Results and Highlights Strategic Expansion Following Nautical Ventures Acquisition
- ALLUONE Launches Customized Solution as the Plant-Care Market Continues to Grow
- Nagarro s'tend au Japon avec l'acquisition d'Inaho Digital Solutions
- Bitwise Asset Management Unleashes the Bitwise Dogecoin ETF (NYSE: BWOW)